Liraglutide
- Product NDC
- 0480-3667
- 11-digit product format
- 004803667
- Labeler code
- 0480
- Product ID
- 0480-3667_57c9f463-a1b8-4efa-8982-40175cf6cf4f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- liraglutide
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- NDA022341
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2024-06-24
- Substance
- LIRAGLUTIDE
- Active strength
- 6 mg/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 839I73S42A | LIRAGLUTIDE | 204656-20-2 | LIRAGLUTIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 0480-3667-20 | 00480366720 | 2 SYRINGE, PLASTIC in 1 CARTON (0480-3667-20) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19) | 2024-06-24 | No | No | Historical |
| 0480-3667-22 | 00480366722 | 3 SYRINGE, PLASTIC in 1 CARTON (0480-3667-22) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19) | 2024-06-24 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Liraglutide | Teva Pharmaceuticals USA, Inc. | 2026-01-30 | HUMAN PRESCRIPTION DRUG LABEL | 3 |
| Liraglutide | A-S Medication Solutions | 2025-01-30 | HUMAN PRESCRIPTION DRUG LABEL | 1 |